Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Universus Photo ImagingsNSE:UNIVPHOTO +4.27%53 3-Year ROIIC % is 6.69 as of Mar. 2026, which is 687% above its 10-year median of 0.85. GuruFocus rates NSE:UNIVPHOTO with a GF Score™ of 53/100 and a GF Value™ of ₹175.37 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Universus Photo Imagings ranks better than 57.23% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Universus Photo Imagings's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 6.69%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Universus Photo Imagings's 3-Year ROIIC % or its related term are showing as below:
NSE:UNIVPHOTO's 3-Year ROIIC % is ranked better than 57.23% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs NSE:UNIVPHOTO: 6.69
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Universus Photo Imagings 3-Year ROIIC % Related Terms
Universus Photo Imagings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:UNIVPHOTO vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Universus Photo Imagings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universus Photo Imagings 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Universus Photo Imagings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Universus Photo Imagings's 3-Year ROIIC % falls into.
Universus Photo Imagings's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -4.1 (Mar. 2026) - 74.38 (Mar. 2023) )
/
( 5511 (Mar. 2026) - 6683.48 (Mar. 2023) )
=
-78.48
/
-1172.48
=
6.69%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Universus Photo Imagings (NSE:UNIVPHOTO) has a 3-Year ROIIC % of 6.69 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Universus Photo Imagings and its competitors. This is 687% above median its historical median of 0.85. According to the industry distribution chart, Universus Photo Imagings ranks #340 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 42.8%.
Is Universus Photo Imagings' 3-Year ROIIC % too high?
Universus Photo Imagings' current 3-Year ROIIC % of 6.69 is 687% above median its 10-year median of 0.85. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. Universus Photo Imagings' value of 6.69 is 355.1% above this industry median. Based on the distribution chart, Universus Photo Imagings ranks #340 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Universus Photo Imagings has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universus Photo Imagings' 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Universus Photo Imagings ranks #340 out of 795 companies for 3-Year ROIIC %. This puts Universus Photo Imagings in the upper half of its industry. The industry median 3-Year ROIIC % is 1.47. Universus Photo Imagings' value of 6.69 is 355.1% above this benchmark. While the company's 10-year median is 0.85 vs. the industry median of 1.47, Universus Photo Imagings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Universus Photo Imagings's current 3-Year ROIIC % of 6.69 is 355.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Universus Photo Imagings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universus Photo Imagings's current 3-Year ROIIC % is 6.69, which is 687% above median its own 10-year median of 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universus Photo Imagings stock overvalued right now?
Based on GuruFocus' analysis, Universus Photo Imagings (NSE:UNIVPHOTO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹175.37, compared to a current price of ₹436.30 — trading 148.8% above its estimated fair value. The current 3-Year ROIIC % is 6.69, which is 687% above median its 10-year median of 0.85 and 355.1% above the Medical Devices & Instruments industry median of 1.47. Universus Photo Imagings' overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Universus Photo Imagings (NSE:UNIVPHOTO), the current 3-Year ROIIC % is 6.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universus Photo Imagings (NSE:UNIVPHOTO) Overvalued in 2026?
Based on GuruFocus' analysis, Universus Photo Imagings stock appears to be overvalued.
The current stock price of ₹436.30 is trading 148.8% above its estimated GF Value™ of ₹175.37.
GuruFocus considers Universus Photo Imagings to be Significantly Overvalued.
Key valuation signals for NSE:UNIVPHOTO:
3-Year ROIIC %: 6.69 (687% above median its 10-year median of 0.85)
GF Value™: ₹175.37 vs. price of ₹436.30 (148.8% above fair value)
Industry Position: 355.1% above the Medical Devices & Instruments median (#340 of 795)
No single metric tells the full story. See the NSE:UNIVPHOTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universus Photo Imagings Ltd specializes in manufacturing, selling, distributing, converting, and producing X-ray films and NTR (non-toxic radiographic) films with matt and glossy finishes. These films are used for medical imaging and various photographic applications such as photo albums, certificates, playing cards, gift cards, visiting cards, calendars, menu cards, wedding cards, and modeling portfolios. The company operates a high-tech manufacturing facility located at Dadra in the Union Territory of Dadra and Nagar Haveli, India. Revenue is generated through the sale of these imaging products to medical and photographic industries.
53GF Score
Get the complete analysis for NSE:UNIVPHOTO
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNIVPHOTO has been successfully added to your 
